Insulin glargine and lixisenatide Subcutaneous and Metformin and pioglitazone
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Metformin and pioglitazone and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: metformin / pioglitazone
Brand name: Actoplus Met, Actoplus Met XR
Synonyms: Pioglitazone and Metformin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Metformin and repaglinide
- Insulin glargine and lixisenatide Subcutaneous-Metformin and saxagliptin
- Insulin glargine and lixisenatide Subcutaneous-Metformin and sitagliptin
- Insulin glargine and lixisenatide Subcutaneous-Metformin Extended-Release Tablets
- Insulin glargine and lixisenatide Subcutaneous-Metformin Hydrochloride
- Insulin glargine and lixisenatide Subcutaneous-Metformin Oral Solution
- Metformin and pioglitazone-Insulin glargine, recombinant Subcutaneous
- Metformin and pioglitazone-Insulin glulisine
- Metformin and pioglitazone-Insulin Glulisine (Cartridges and Pens)
- Metformin and pioglitazone-Insulin Glulisine (Vials)
- Metformin and pioglitazone-Insulin glulisine Subcutaneous
- Metformin and pioglitazone-Insulin human inhaled Inhalation